IDEXX Laboratories, Inc. IDXX is well-poised to grow in the upcoming quarters due to the performance of its CAG (Companion Animal Group) Diagnostics business. The consistent growth in international ...

IDEXX Laboratories' oncology panel and share buybacks boost outlook. Read why IDXX stock is upgraded to buy with growth ...

Company Overview and Recent Performance IDEXX Laboratories has established itself as a prominent player in the veterinary diagnostics and software industry. The company's stock has shown notable ...

The Companion Animal Group diagnostics segment registered a 6% growth, driving the overall positive earnings performance. Idexx Laboratories exceeded earnings expectations for Q4 2024, buoyed by ...

The pet care industry is growing, providing IDEXX with significant growth opportunities. Check out why I rate IDXX stock as a ...

IDEXX Laboratories, Inc. engages in the development ... The CAG segment provides diagnostic and information management-based products and services for the companion animal veterinary industry ...

Idexx Laboratories has steadily increased its scale and reach in the veterinary diagnostic lab business to dig a wide moat. It is well-positioned to benefit from two key trends. First, pet ...

Idexx Laboratories, a global leader in veterinary diagnostics, focuses on providing a wide range of diagnostic products and services for veterinarians worldwide. Its operations are primarily ...

IDEXX Laboratories, Inc. IDXX is well-poised to grow in the upcoming quarters due to the performance of its CAG (Companion Animal Group) Diagnostics business. The consistent growth in ...

Strong Global Performance: IDEXX is focused on growing its global commercial capability to sustain strong CAG Diagnostics recurring revenue growth. The expanded global commercial capability is ...